title: Cancer care Ontario guideline recommendations for hormone receptor testing in breast cancer.
abstract: Hormone receptor testing (oestrogen and progesterone) in breast cancer at the time of primary diagnosis is used to guide treatment decisions. Accurate and standardised testing methods are critical to ensure the proper classification of the patient's hormone receptor status. Recommendations were developed to improve the quality and accuracy of hormone receptor testing based on a systematic review conducted jointly by the American Society of Clinical Oncology/College of American Pathologists and Cancer Care Ontario's Program in Evidence-Based Care. Evidence-based recommendations were formulated to set standards for optimising immunohistochemistry in assessing hormone receptor status, as well as assuring quality and proficiency between and within laboratories. A formal external review was conducted to validate the relevance of these recommendations. It is anticipated that widespread adoption of these guidelines will further improve the accuracy of hormone receptor testing in Canada.
authors.affiliation: Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. Sharon.Nofech-Mozes@sunnybrook.ca
authors.forename: S
authors.initials: S
authors.lastname: Nofech-Mozes
authors.forename: E T
authors.initials: ET
authors.lastname: Vella
authors.forename: S
authors.initials: S
authors.lastname: Dhesy-Thind
authors.forename: W M
authors.initials: WM
authors.lastname: Hanna
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D009376:Neoplasms, Hormone-Dependent / Q000175:diagnosis / Q000378:metabolism; D009864:Ontario; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone